Twist Bioscience: A 'Hold' In DNA Data Storage [Seeking Alpha]
Twist Bioscience Corporation (TWST)
Last twist bioscience corporation earnings: 2/6 04:05 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
The company's revenue-generating segments, particularly DNA synthesis, show high growth and cost reduction potential. Financial discipline and strategic expansion show a path toward profitability, with a solid cash runway supporting near-term operations. Despite its promising business outlook, TWST's stock price is already inflated, leading to a "hold" rating, but I consider it a great buy on dips. Twist Bioscience Corporation ( NASDAQ: TWST ) is a promising bet on DNA applications with synthetic DNA, DNA products, and Next-Generation Sequencing [NGS] tools for researchers in several industries. TWST's IP has applications in health care, materials and chemicals, agriculture, and academic research. The company's Express Genes service effectively expanded TWST's customer base, and as a result, its Q1 2024 report came in above management's guidance. Yet, despite all these positives, my valuation analysis suggests TWST's stock price already reflects this potential, trading at a rel
Show less
Read more
Impact Snapshot
Event Time:
TWST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TWST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TWST alerts
High impacting Twist Bioscience Corporation news events
Weekly update
A roundup of the hottest topics
TWST
News
- Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024Business Wire
- Twist Bioscience Co. (NASDAQ: TWST) had its price target lowered by analysts at Barclays PLC from $45.00 to $40.00. They now have an "overweight" rating on the stock.MarketBeat
- Despite shrinking by US$135m in the past week, Twist Bioscience (NASDAQ:TWST) shareholders are still up 132% over 1 year [Yahoo! Finance]Yahoo! Finance
- Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations [Yahoo! Finance]Yahoo! Finance
- Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse PopulationsBusiness Wire
TWST
Earnings
- 2/2/24 - Beat
TWST
Sec Filings
- 4/25/24 - Form 4
- 4/23/24 - Form 144
- 4/11/24 - Form 4
- TWST's page on the SEC website